IL-12-mediated activation triggers the release of Th1 cytokines like IFN-γ, resulting in inhibition of Treg lymphocytes and increased expression of MHC class I molecules on tumor cells facilitating recognition [52,53]. The gene discussed is IFNG; the disease is neoplasm.